Giovanni Simone Selected Research

Giovanni Simone Research Topics

Disease

29	Neoplasms (Cancer) 04/2018 - 09/2006
19	Breast Neoplasms (Breast Cancer) 04/2018 - 09/2002
9	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2012
6	Colorectal Neoplasms (Colorectal Cancer) 10/2016 - 09/2010
5	Hypoxia (Hypoxemia) 01/2016 - 11/2011
4	Stomach Neoplasms (Stomach Cancer) 01/2018 - 09/2006
4	Colonic Neoplasms (Colon Cancer) 01/2018 - 02/2013
3	Carcinogenesis 01/2018 - 01/2008
3	Circulating Neoplastic Cells 11/2014 - 02/2013
3	Infections 07/2012 - 01/2006
2	Lymphatic Metastasis 01/2017 - 06/2012
2	Adenocarcinoma of Lung 02/2016 - 09/2015
2	Lung Neoplasms (Lung Cancer) 02/2016 - 07/2013
2	Familial Breast Cancer 06/2013 - 01/2013
2	Hepatocellular Carcinoma (Hepatoma) 07/2012 - 01/2008
2	Virus Diseases (Viral Diseases) 07/2012 - 01/2008
1	Melanoma (Melanoma, Malignant) 01/2018
1	Thyroid Neoplasms (Thyroid Cancer) 01/2017
1	Anaplastic Thyroid Carcinoma 01/2017
1	Triple Negative Breast Neoplasms 10/2016
1	Uterine Neoplasms (Uterine Cancer) 02/2016
1	Chromosomal Instability (Chromosome Stability) 02/2015
1	Genomic Instability 02/2015
1	Residual Neoplasm 11/2014
1	Retinoblastoma (Glioblastoma, Retinal) 01/2014
1	Adenocarcinoma 01/2014
1	Disease Progression 12/2013
1	Lymphoma (Lymphomas) 12/2013
1	Carcinoma (Carcinomatosis) 04/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2010
1	Ductal Carcinoma 07/2009

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2009
7	Biological ProductsIBA 11/2016 - 09/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 09/2006
6	Biomarkers (Surrogate Marker)IBA 11/2017 - 11/2011
6	DNA (Deoxyribonucleic Acid)IBA 07/2013 - 01/2006
4	Progesterone Receptors (Progesterone Receptor)IBA 11/2017 - 09/2012
4	Estrogen ReceptorsIBA 09/2015 - 01/2007
3	Tryptases (Tryptase)IBA 04/2018 - 06/2011
3	sodium-hydrogen exchanger regulatory factorIBA 09/2017 - 11/2011
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2017 - 01/2015
3	human ERBB2 proteinIBA 11/2016 - 11/2011
3	MicroRNAs (MicroRNA)IBA 01/2016 - 06/2013
3	Capecitabine (Xeloda)FDA Link 01/2016 - 11/2013
3	Sodium-Hydrogen ExchangersIBA 06/2015 - 06/2011
3	ParaffinIBA 01/2015 - 09/2002
3	Plasminogen Activator Inhibitor 1IBA 11/2014 - 01/2008
3	Hormones (Hormone)IBA 01/2013 - 03/2012
2	CateninsIBA 10/2017 - 10/2016
2	Estrogens (Estrogen)FDA Link 10/2016 - 11/2013
2	Epirubicin (Ellence)FDA LinkGeneric 01/2016 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 09/2015 - 09/2010
2	Tyrosine Kinase InhibitorsIBA 09/2015 - 09/2010
2	Formaldehyde (Formol)FDA Link 01/2015 - 09/2002
2	AntigensIBA 04/2013 - 07/2012
2	Monoclonal AntibodiesIBA 04/2013 - 09/2010
2	Plasminogen Activators (Plasminogen Activator)IBA 07/2012 - 01/2008
2	Tumor Biomarkers (Tumor Markers)IBA 03/2012 - 07/2009
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2011 - 09/2006
2	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2009 - 01/2008
1	Transcription Factors (Transcription Factor)IBA 04/2018
1	Wnt ReceptorsIBA 01/2018
1	Pharmaceutical PreparationsIBA 08/2017
1	AntioxidantsIBA 08/2017
1	Adenosine Monophosphate (AMP)IBA 01/2017
1	Thyroglobulin FDA Link 01/2017
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 10/2016
1	Progesterone FDA LinkGeneric 10/2016
1	Poly (ADP-Ribose) Polymerase-1IBA 05/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2016
1	Adenosine Diphosphate Ribose (ADP-Ribose)IBA 05/2016
1	Adenosine Diphosphate (ADP)IBA 05/2016
1	BRCA1 ProteinIBA 05/2016
1	CrizotinibIBA 02/2016
1	Anaplastic Lymphoma KinaseIBA 02/2016
1	Codon (Codons)IBA 09/2015
1	Indicators and Reagents (Reagents)IBA 02/2015
1	Environmental BiomarkersIBA 11/2014
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2014
1	CytokinesIBA 11/2014
1	Thymidylate SynthaseIBA 09/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2014
1	trioctyl phosphine oxide (TOPO)IBA 09/2014
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 09/2014
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2014
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2014
1	Trastuzumab (Herceptin)FDA Link 11/2013
1	Lapatinib (GW572016)FDA Link 11/2013
1	PAR-2 ReceptorIBA 08/2013
1	Peptide Hydrolases (Proteases)FDA Link 08/2013
1	RNA (Ribonucleic Acid)IBA 07/2013
1	Epidermal Growth Factor (EGF)IBA 04/2013
1	Transforming Growth Factors (Transforming Growth Factor)IBA 04/2013
1	CXC ChemokinesIBA 04/2013
1	Keratin-7 (Cytokeratin 7)IBA 04/2013
1	Phenobarbital (Luminal)FDA Link 09/2012
1	Cell-Free Nucleic AcidsIBA 07/2009

Therapy/Procedure

10	Therapeutics 01/2018 - 09/2012
3	Drug Therapy (Chemotherapy) 02/2016 - 01/2015
2	Adjuvant Chemotherapy 09/2015 - 11/2013